Neurology · 1991 · 70 citations · 0 references
PharmacyNeurologyPharmacotherapyClinical PharmacologyPain ManagementPain MedicineMedication UseMultiple SclerosisMultiple Sclerosis PharmacotherapyPolypharmacy ConsiderationsSpasticity ManagementSpasticity PharmacotherapyMultiple Sclerosis SpasticityMultiple Sclerosis Therapy
We reviewed a 10% random sample of charts from an outpatient clinic for multiple sclerosis to determine the frequency with which baclofen was prescribed for spasticity in high doses (greater than 80 mg/d). About 20% of patients had taken high-dose baclofen, and 15% were still receiving a high dose. Taking a high dose was not associated with discontinuing treatment.